Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


US military marks 11th successive night of attacks on Iran
Indian opposition disrupts parliament to support student protesters and pressure Modi
Rubio says US still willing to negotiate over Iran crisis
House fire kills 10 in Peru's capital, including five minors
Ukraine will step up counteroffensive actions, Zelenskyy's new top commander says
